Laura Clague is CFO at Travere Therapeutics, Inc. (RTRX). They have made 16 open-market trades across 5 companies since 2008, most recently 2023-06-14.
CIK 0001388773
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $870 since 2008, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TVTX | SELL · 10b5-1 | 2022-05-10 | 2022-05-12 | $21.51 | $47K | +1.5% | +6.1% | +29.1% |
| GNSS | SELL | 2022-02-23 | 2022-02-24 | $3.14 | $43K | -12.1% | -17.1% | -4.1% |
| TVTX | SELL · 10b5-1 | 2022-01-31 | 2022-02-02 | $27.40 | $34K | +9.3% | +2.7% | +0.3% |
| TVTX | SELL | 2022-01-24 | 2022-01-26 | $24.98 | $103K | +4.5% | +0.8% | -0.4% |
| TVTX | SELL | 2022-01-11 | 2022-01-12 | $27.40 | $206K | -0.0% | +5.7% | +8.0% |
| TVTX | SELL | 2021-08-17 | 2021-08-17 | $17.12 | $24K | +9.6% | +14.3% | +49.6% |
| TVTX | SELL · 10b5-1 | 2021-05-11 | 2021-05-13 | $19.30 | $77K | -5.5% | -17.6% | -24.3% |
| GNSS | SELL | 2021-03-10 | 2021-03-12 | $7.42 | $40K | -9.3% | -8.6% | -34.1% |
| TVTX | SELL | 2021-02-05 | 2021-02-09 | $31.47 | $212K | -0.9% | -3.9% | -33.8% |
| TVTX | SELL | 2021-02-03 | 2021-02-03 | $28.91 | $105K | -9.8% | -13.6% | -23.2% |
| TVTX | SELL | 2021-02-02 | 2021-02-02 | $30.75 | $111K | -8.8% | -8.9% | -14.3% |
| RTRX | SELL | 2020-11-24 | 2020-11-25 | $23.29 | $175K | N/A | N/A | N/A |
| RTRX | SELL | 2020-11-16 | 2020-11-17 | $23.98 | $180K | N/A | N/A | N/A |
| RTRX | SELL | 2020-11-13 | 2020-11-13 | $23.61 | $177K | N/A | N/A | N/A |
| RTRX | SELL · 10b5-1 | 2020-09-23 | 2020-09-23 | $18.48 | $28K | +15.5% | +20.1% | N/A |
| RTRX | SELL · 10b5-1 | 2020-09-22 | 2020-09-22 | $18.59 | $28K | +3.7% | +14.1% | N/A |
| RTRX | SELL · 10b5-1 | 2020-05-11 | 2020-05-13 | $16.22 | $49K | +5.4% | +1.5% | +21.1% |
| RTRX | SELL | 2020-03-10 | 2020-03-12 | $15.02 | $60K | -12.6% | +18.7% | +10.7% |
| RTRX | SELL · 10b5-1 | 2019-05-15 | 2019-05-16 | $18.25 | $46K | +2.7% | +8.2% | -5.9% |
| RTRX | SELL · 10b5-1 | 2019-02-11 | 2019-02-13 | $21.44 | $44K | +0.2% | +7.4% | -15.7% |
| RTRX | SELL | 2018-12-20 | 2018-12-21 | $21.88 | $226K | +12.3% | +4.0% | +14.2% |
| RTRX | SELL | 2018-11-14 | 2018-11-16 | $23.96 | $331K | -3.4% | -9.1% | -16.7% |
| LRAD | SELL | 2013-09-04 | 2013-09-06 | $1.54 | $14K | -11.1% | -3.0% | -3.0% |
| ATCO | BUY | 2008-12-11 | 2008-12-15 | $0.44 | $870 | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.